The company
Prenetics Global Limited - Class A Ordinary Share
PRE · Nasdaq
PRE stood above a rising 150-day average in 45 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 7.3% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Just dropped out
- Weeks in an uptrend
- out for 1
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $2.0M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 4
- Institutions holding
- 25 (-6)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 45 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
4 disclosed lines: House 1, Senate 3, executive 0; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Susan M. Collins Senate: U.S. Senate eFDSenator | soldspouse | $1k–$15k | 19 Jun 2014filed 20 Jul 2015 |
| Susan M. Collins Senate: U.S. Senate eFDSenator | soldspouse | $1k–$15k | 19 Jun 2014filed 13 May 2015 |
| Susan M. Collins Senate: U.S. Senate eFDSenator | soldspouse | $1k–$15k | 19 Jun 2014filed 27 Jun 2014 |
| Lois Frankel House: U.S. House ClerkFL22 | sold | $1k–$15k | 12 Jun 2014filed 18 Jun 2014 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Brian J. RosinCFO of IM8 (US) LLC | bought | 5,100at $22.80 | 25 Aug 2026filed 26 Aug 2026 |
| Danny Sheng Wu YeungChief Executive Officer | bought | 6,000at $20.90 | 24 Aug 2026filed 24 Aug 2026 |
| Danny Sheng Wu YeungChief Executive Officer | bought | 11,181at $21.40 | 24 Aug 2026filed 24 Aug 2026 |
| Brian J. RosinCFO of IM8 (US) LLC | bought | 18,000at $21.19 | 24 Aug 2026filed 26 Aug 2026 |
| Danny Sheng Wu YeungChief Executive Officer | bought | 7,500at $18.31 | 20 Aug 2026filed 24 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Prospect Capital Advisors, LLCnew · filed 14 Aug 2026 | 235,800$4.5M | +235,800 |
| JANE STREET GROUP, LLCadded · filed 14 Aug 2026 | 225,093$4.3M | +182,907+433.6% |
| GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026 | 168,733$3.2M | -24,850−12.8% |
| MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026 | 126,086$2.4M | -66,514−34.5% |
| Tenzing Global Management, LLCreduced · filed 14 Aug 2026 | 125,000$2.4M | -75,000−37.5% |
| MARSHALL WACE, LLPreduced · filed 13 Aug 2026 | 47,327$905K | -26,005−35.5% |
| NOMURA HOLDINGS INCreduced · filed 14 Aug 2026 | 42,101$805K | -33,518−44.3% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPadded · filed 14 Aug 2026 | 38,126$729K | +5,002+15.1% |
| UBS Group AGadded · filed 13 Aug 2026 | 37,040$708K | +10,267+38.3% |
| XTX Topco Ltdreduced · filed 14 Aug 2026 | 30,485$583K | -2,932−8.8% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.